FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3092111000001106: Implant (product)

  • Implant

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
14610701000001119 Implant (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
14610801000001111 Implant en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Gentamicin 75mg implant Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Gentamicin 225mg implant Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Gentamicin 28mg implant Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Carmustine 7.7mg implant Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Dibotermin alfa 12mg powder and solvent and matrix for implantation matrix Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Human fibrinogen 5.5mg/square cm / Human thrombin 2units/square cm implant 4.8cm x 9.5cm Has manufactured dose form False Implant Inferred relationship Existential restriction modifier
Etonogestrel 68mg subdermal implant Has manufactured dose form False Implant Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start